Global /South Korea /Healthcare /Biotechnology /064550
chevron_leftBack
Bioneer Corp. logo

Bioneer Corp.

064550
KRX: 064550 Delayed
10,540KRW -3.4%
6.88 USD
As of 5 June 2026, Bioneer Corp. has a market cap of $183.71M USD, ranking #21636 globally and #867 in South Korea. It ranks #1942 in the Healthcare sector, and #377 in the Biotechnology industry.
Global Rank
21636
Country Rank
867
Sector Rank
1942
Industry Rank
377
Key Stats
Market Cap
$183.71MUSD
281.59B KRW
Enterprise Value
$204.06MUSD
312.79B KRW
Revenue (TTM)
$215.36MUSD
330.11B KRW
EBITDA (TTM)
$15.78MUSD
24.19B KRW
Net Income (TTM)
-$1.84MUSD
-2.81B KRW
EBITDA Margin
7.3%
Profit Margin
-0.9%
PS Ratio
0.9
PB Ratio
1.2
EV/EBITDA
12.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Han-Oh Park open_in_new
Employees
367
Founded
1992
Website
bioneer.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-3.4% -1.4% -9.1% -21% -23% -32%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
064550
(주)바이오니아
ISIN: KR7064550007
Shares Out.:
25.81M1 Shares Float: 21.196M2
TV:
SA:
YF:
GF:
BA:
MS:
10,540 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Bioneer Corp.

Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, and electrophoresis. It also provides molecular diagnosis, including MDx technologies, human diagnostics kits, MDx extraction kits, and instruments; and products for animal, aquatic-bio, mosquito-borne, and plant diseases, as well as food safety, human pathogen, and nano-bio products. The company was founded in 1992 and is headquartered in Daejeon, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)
Name
Market Cap diff.
PE
$44.48B
68.19T KRW
24K%
35.5
068270
$27.89B
42.76T KRW
15K%
43.8
196170
$13.27B
20.33T KRW
7K%
146.6
028300
$5.46B
8.37T KRW
3K%
-
087010
$3.96B
6.07T KRW
2K%
-
$2.23B
3.42T KRW
1K%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
99K%
23.9
GILD
$159.92B
87K%
19.0
ARGX
$48.01B
41.39B EUR
26K%
39.9
CSL
$43.01B
60.27B AUD
23K%
29.3
LONN
$42.55B
33.71B CHF
23K%
37.2
NTRA
$27.6B
15K%
-
chevron_leftBack